Evidence map›Paper›PMID 40390539›Full record

ArticleJournal of the American Geriatrics Society2025

Moderate Impairment in Binocular Contrast Sensitivity Predicts Faster Mobility Decline in Cognitively Unimpaired Older Adults.

Ashley Wells, Michael E Miller, Haiying Chen, Paul J Laurienti, Stephen B Kritchevsky, Atalie C Thompson

Abstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ashley WellsWake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0009-0007-2242-8146
Michael E MillerDivision of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Haiying ChenDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Paul J LaurientiDepartment of Radiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Stephen B KritchevskyDivision of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Atalie C ThompsonDivision of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

Funding

Wake Forest Claude D. Pepper OAIC - RenewalP30AG021332 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Denise Kathryn Houston · 2002 to 2026
$36.4M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Combining assessment of cognition, eye movement, and gait in naturalistic settings to differentiate subclinical Alzheimer's pathology.R01AG052419 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KRITCHEVSKY, STEPHEN B., LAURIENTI, PAUL · 2017 to 2022
$4.2M
Deep learning to quantify glaucomatous damage on fundus photographs for teleophthalmologyK23EY030897 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI THOMPSON, ATALIE C · 2020 to 2024
$968k
NCATS NIH HHS UL1 TR001420NCATS NIH HHS UL1-TR001420NEI NIH HHS K23 EY030897NEI NIH HHS K23EY030897NIA NIH HHS P30 AG021332NIA NIH HHS P30-AG021332NIA NIH HHS R01 AG052419NIA NIH HHS R01-AG052419
6 · The paper itself

Abstract

backgroundImpaired contrast sensitivity (CS) commonly occurs in older adults but has been largely overlooked as a contributing factor to functional impairment and decline. We examined if CS impairment predicts decline in performance on the expanded short physical performance battery (eSPPB) over 30 months of follow-up in cognitively healthy older adults.

methodsSingle center prospective cohort study of 192 cognitively unimpaired older adults with good visual acuity and self-reported visual function. Linear mixed models examined the difference in the association of moderately impaired baseline CS (logCS < 1.55) with performance on the eSPPB and its components-balance, 4 m gait speed, narrow walk, and chair pace-over 30 months. Multivariable models adjusted for the effect of age, race, and sex on the slopes over time.

resultsAt baseline, the mean participant age was 76.5 ± 4.7 years, with 56.5% (N = 108) female and 9.4% (N = 18) black. Participants with moderately impaired CS at baseline had a significantly faster decline in eSPPB over a 30-month period (Beta: -0.115, 95% CI (-0.180, -0.050), p < 0.001) compared with those with normal CS (Beta: -0.022, 95% CI (-0.044, -0.001), p = 0.042). There was a difference in slopes of -0.093 units/year ((95% CI, -0.161, -0.024), p = 0.009) between groups. This difference in slopes remained significant after adjusting for the effect of age, sex, and race (difference in slopes -0.086, 95% CI (-0.155, -0.016), p = 0.016). Impaired CS predicted significantly greater declines in balance over 30 months (difference in slopes -3.512 (-6.826, -0.199), p = 0.0378), but the differences in gait speed, narrow walk, and chair pace were not significant.

conclusionsIn cognitively intact older adults with good visual acuity, moderately impaired CS was associated with a significantly faster decline in eSPPB, especially balance, over 30 months of follow-up. A relatively simple test of vision may identify a subset of older adults without cognitive dysfunction who are at risk for mobility decline.

Indexed as

Contrast SensitivityMobility LimitationVision, BinocularVision DisordersAgedAged, 80 and overFemaleHumansMalePhysical Functional PerformanceProspective StudiesVisual AcuityWalking Speedcognitively unimpairedcontrast sensitivitymobility

Identifiers

PMID40390539
PMCPMC12213130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.